Please try another search
Aroa Biosurgery Limited engages in the development, manufacture, and sale of medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine; and OviTex and OviTex PRS, a reinforced bioscaffolds for use in hernia repair and abdominal wall reconstruction, as well as breast reconstruction. The company also offers Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.
Name | Age | Since | Title |
---|---|---|---|
Brian Ward | - | 2007 | Founder, CEO, MD & Executive Director |
John Richard Pinion | 55 | 2015 | Independent Non-Executive Director |
James Neil McLean | - | 2011 | Independent Non-Executive Chairperson |
Philip McCaw | - | 2008 | Non-Executive Director |
John Flower Diddams | 74 | 2019 | Independent Non-Executive Director |
Catherine Mohr | 55 | 2022 | Independent Non-Executive Director |
Darla Hutton | - | 2024 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review